Comparable Helicobacter pylori eradication rates obtained with 4- and 7-day rabeprazole-based triple therapy: a preliminary study (Q44692617)

5 December 2017

Comparable Helicobacter pylori eradication rates obtained with 4- and 7-day rabeprazole-based triple therapy: a preliminary study (English)

1 reference

5 December 2017

1 reference

5

1 reference

5 December 2017

C Gambaro

1

1 reference

5 December 2017

C Bilardi

2

1 reference

5 December 2017

P Dulbecco

3

1 reference

5 December 2017

E Iiritano

4

1 reference

5 December 2017

C Mansia

6

1 reference

5 December 2017

P Usai

7

1 reference

5 December 2017

S Vigneri

8

1 reference

5 December 2017

V Savarino

9

1 reference

5 December 2017

1 November 2003

1 reference

Digestive and Liver Disease

5 December 2017

1 reference

5 December 2017

35

1 reference

5 December 2017

11

1 reference

5 December 2017

763-767

1 reference

Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study

5 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900458-4

7 January 2021

Regular review: treatment of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900458-4

7 January 2021

Treatment of Helicobacter pylori infection. Indications and regimens: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900458-4

7 January 2021

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900458-4

7 January 2021

Guidelines for the management of Helicobacter pylori infection. Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900458-4

7 January 2021

Treatment of Helicobacter pylori infection: a review of the world literature

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900458-4

7 January 2021

Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900458-4

7 January 2021

A proton pump inhibitor, E3810, has antibacterial activity through binding to Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900458-4

7 January 2021

Comparison of Isotope Ratio Mass Spectrometry and Nondispersive Isotope-Selective Infrared Spectroscopy for 13C-Urea Breath Test

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900458-4

7 January 2021

A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900458-4

7 January 2021

A novel action of the proton pump inhibitor rabeprazole and its thioether derivative against the motility of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900458-4

7 January 2021

Comparison of the kinetic disposition and metabolism of E3810, a new proton pump inhibitor, and omeprazole in relation to S-mephenytoin 4'-hydroxylation status

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900458-4

7 January 2021

Review article: cytochrome P450 and the metabolism of proton pump inhibitors--emphasis on rabeprazole

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900458-4

7 January 2021

Proton pump inhibitors--differences emerge in hepatic metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900458-4

7 January 2021

Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900458-4

7 January 2021

S-mephenytoin hydroxylation phenotypes in a Swedish population determined after coadministration with debrisoquin

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900458-4

7 January 2021

Phenotyping polymorphic drug metabolism in the French Caucasian population

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900458-4

7 January 2021

Lansoprazole triple therapy for Helicobacter pylori--is 5 days enough?

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900458-4

7 January 2021

Equally high efficacy of 4, 7 and 10-day triple therapies to eradicate Helicobacter pylori infection in patients with ulcer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900458-4

7 January 2021

Systematic review: Rabeprazole-based therapies in Helicobacter pylori eradication.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900458-4

7 January 2021

Evaluation of short-term low-dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomized, double-blind, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900458-4

7 January 2021

The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900458-4

7 January 2021

The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900458-4

7 January 2021

Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900458-4

7 January 2021

5-day vs. 7-day triple therapy with rabeprazole, clarithromycin and amoxicillin for Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900458-4

7 January 2021

Rabeprazole-based 3-day and 7-day triple therapy vs. omeprazole-based 7-day triple therapy for the treatment of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900458-4

7 January 2021

10.1016/S1590-8658(03)00458-4

Identifiers

DOI

1 reference

5 December 2017

1 reference